Amanda Koh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amanda Koh has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Dhanny Gomez
Nottingham University Hospitals NHS Trust, Nottingham, UK
6 shared publications Adam Brooks
Nottingham University Hospitals NHS Trust , Nottingham
5 shared publications- Alfred Adiamah
Nottingham Digestive Diseases Centre and National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK
5 shared publications - Dimitrios Karavias
University Hospital Southampton NHS Foundation Trust , Southampton
4 shared publications Lauren Blackburn
Nottingham University Hospitals NHS Trust , Nottingham
4 shared publicationsAdam Frampton
Royal Surrey Hospital , London
3 shared publications
Latest Publications
- 21 April 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (8)
Management of incidental gallbladder cancer in a nationwide CAPBIL study
Introduction: To provide contemporary, real-world data on the management approaches and survival outcomes of patients with incidental gallbladder cancer (GBC) following cholecystectomy in the United Kingdom. The secondary aim was to identify prognostic factors associated with survival. Methods: Patients diagnosed with incidental GBC following cholecystectomy between January 2014 and December 2022 across 24 centres were included. Data collected comprised demographics, treatment details, histopathological findings and survival outcomes. Results: During the study period, 285 patients had incidental GBC. Median follow-up was 31 months, with 5-year disease-free (DFS) and overall (OS) survival of 41.5% and 45.1%, respectively. Of the 193 (67.7%) patients who underwent liver resection, most (97.9%) underwent segment 4B/5 resection. Patients with incidental GBC who underwent liver resection had significantly improved DFS (51 vs 15 months, p<0.001) and OS (72 vs 26 months, p<0.001) compared with those who did not. In addition, patients who completed adjuvant chemotherapy had better DFS (35 vs 15 months, p=0.021) and OS (47 vs 26 months, p=0.009) compared to those who did not. On multivariable analysis, nodal metastases were independently associated with poorer DFS (HR 2.04, 95% CI 1.30–3.20, p=0.002), while advanced tumour (T3–T4) stage (HR 1.70, 95% CI 1.04-2.77, p=0.034) and nodal metastases (HR 2.15, 95% CI 1.33–3.48, p=0.002) predicted poorer OS. Conclusion: Patients who underwent liver resection after incidental GBC had significantly better survival than those who did not proceed to further surgery. Adverse tumour biology was associated with poorer survival.
- 21 April 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (8)
Management of incidental gallbladder cancer in a nationwide CAPBIL study
Introduction: To provide contemporary, real-world data on the management approaches and survival outcomes of patients with incidental gallbladder cancer (GBC) following cholecystectomy in the United Kingdom. The secondary aim was to identify prognostic factors associated with survival. Methods: Patients diagnosed with incidental GBC following cholecystectomy between January 2014 and December 2022 across 24 centres were included. Data collected comprised demographics, treatment details, histopathological findings and survival outcomes. Results: During the study period, 285 patients had incidental GBC. Median follow-up was 31 months, with 5-year disease-free (DFS) and overall (OS) survival of 41.5% and 45.1%, respectively. Of the 193 (67.7%) patients who underwent liver resection, most (97.9%) underwent segment 4B/5 resection. Patients with incidental GBC who underwent liver resection had significantly improved DFS (51 vs 15 months, p<0.001) and OS (72 vs 26 months, p<0.001) compared with those who did not. In addition, patients who completed adjuvant chemotherapy had better DFS (35 vs 15 months, p=0.021) and OS (47 vs 26 months, p=0.009) compared to those who did not. On multivariable analysis, nodal metastases were independently associated with poorer DFS (HR 2.04, 95% CI 1.30–3.20, p=0.002), while advanced tumour (T3–T4) stage (HR 1.70, 95% CI 1.04-2.77, p=0.034) and nodal metastases (HR 2.15, 95% CI 1.33–3.48, p=0.002) predicted poorer OS. Conclusion: Patients who underwent liver resection after incidental GBC had significantly better survival than those who did not proceed to further surgery. Adverse tumour biology was associated with poorer survival.
- 23 January 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (2)
Adherence to best practice guidelines for the management of intrahepatic cholangiocarcinoma: results from the CAPBIL study
- 23 January 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (2)
Adherence to best practice guidelines for the management of intrahepatic cholangiocarcinoma: results from the CAPBIL study
- 14 January 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (2) , 543-544
Authors' Reply: The Influence of Socioeconomic Status on Management and Outcomes in Major Trauma: A Systematic Review and Meta‐Analysis
- 14 January 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (2) , 543-544
Authors' Reply: The Influence of Socioeconomic Status on Management and Outcomes in Major Trauma: A Systematic Review and Meta‐Analysis
- Open Access
- 10 December 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (3) , 703-712
Correlation between Altmetric Attention Scores and citation scores across the high impact-factor journals each in Medicine, Surgery, and Anaesthesia
- 10 December 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (3) , 703-712
Open AccessCorrelation between Altmetric Attention Scores and citation scores across the high impact-factor journals each in Medicine, Surgery, and Anaesthesia
- Open Access
- 9 October 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (11) , 2783-2792
The influence of socioeconomic status on management and outcomes in major trauma: A systematic review and meta‐analysis
Background: Major trauma is a leading cause of death and disability in younger individuals and poses a significant public health concern. There is a growing interest in understanding the complex relationships between socioeconomic deprivation and major trauma. Anecdotal evidence suggests that deprivation is associated with more violent and debilitating injuries. There remains a paucity in literature evaluating major trauma outcomes in relation to socioeconomic deprivation.Methods: A comprehensive search of MEDLINE, Embase, and CENTRAL databases was performed to identify studies from 1947 to March 2024. The primary outcome was to establish the distribution of injuries based on deprivation, with secondary outcomes evaluating surgical intervention rates, length of stay, and mortality. Quantitative pooling of data was based on the random‐effects model.Results: Fourteen studies and 878,872 trauma patients were included. A substantial proportion (28%) of trauma incidents occurred in the most deprived group. Patients from the lowest socioeconomic group were considerably younger (weighted mean difference [WMD] −9.85 years and 95% confidence intervals [CI] −9.99 to −9.70) and more likely to be male (odds ratio [OR] 1.36 and 95% CI 1.14–1.63). There were no differences in surgical intervention (OR 1.74 and 95% CI 0.97–3.13), length of stay (WMD 1.15 days and 95% CI −0.32−2.62), and mortality (OR 1.04 and 95% CI 0.95–1.14) regardless of background.Conclusion: Major trauma is prevalent in deprived areas and in younger individuals, with an increasing trend of deprivation in male patients. Although the rates of surgery, length of stay, and mortality did not differ between groups, planning of public health interventions should target areas of higher deprivation.
- 9 October 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (11) , 2783-2792
Open AccessThe influence of socioeconomic status on management and outcomes in major trauma: A systematic review and meta‐analysis
Background: Major trauma is a leading cause of death and disability in younger individuals and poses a significant public health concern. There is a growing interest in understanding the complex relationships between socioeconomic deprivation and major trauma. Anecdotal evidence suggests that deprivation is associated with more violent and debilitating injuries. There remains a paucity in literature evaluating major trauma outcomes in relation to socioeconomic deprivation.Methods: A comprehensive search of MEDLINE, Embase, and CENTRAL databases was performed to identify studies from 1947 to March 2024. The primary outcome was to establish the distribution of injuries based on deprivation, with secondary outcomes evaluating surgical intervention rates, length of stay, and mortality. Quantitative pooling of data was based on the random‐effects model.Results: Fourteen studies and 878,872 trauma patients were included. A substantial proportion (28%) of trauma incidents occurred in the most deprived group. Patients from the lowest socioeconomic group were considerably younger (weighted mean difference [WMD] −9.85 years and 95% confidence intervals [CI] −9.99 to −9.70) and more likely to be male (odds ratio [OR] 1.36 and 95% CI 1.14–1.63). There were no differences in surgical intervention (OR 1.74 and 95% CI 0.97–3.13), length of stay (WMD 1.15 days and 95% CI −0.32−2.62), and mortality (OR 1.04 and 95% CI 0.95–1.14) regardless of background.Conclusion: Major trauma is prevalent in deprived areas and in younger individuals, with an increasing trend of deprivation in male patients. Although the rates of surgery, length of stay, and mortality did not differ between groups, planning of public health interventions should target areas of higher deprivation.
- 5 August 2024
- Published by Wiley in Anz Journal of Surgery
- Vol. 94 (10) , 1693-1701
Systematic review and meta‐analysis of the effect of N‐acetylcysteine on outcomes after liver resection
Background: N‐Acetylcysteine (NAC) is a recognized antioxidative agent that facilitates the conjugation of toxic metabolites. In recent years, NAC has been routinely used to limit ischaemia‐reperfusion injury in liver transplantation. There remains, however, contradictory evidence on its effectiveness in liver resection. This meta‐analysis examines the effectiveness of NAC in improving outcomes following hepatectomy.Methods: A comprehensive search of the MEDLINE, EMBASE, and Cochrane databases was performed to identify relevant randomized controlled trials (RCTs) published since database inception until November 2023. The outcomes of Day 1 biochemical markers (lactate, ALT, bilirubin, and INR), length of stay, transfusion rates, and morbidity were extracted. Quantitative pooling of data was based on a random‐effects model. The study protocol was registered on PROSPERO (Registration no: CRD42023442429).Results: Five RCTs reporting on 388 patients undergoing hepatectomy were included in the analysis. There were no significant differences in patient demographics between groups. Post‐operative lactate was lower in patients receiving NAC (WMD −0.61, 95% CI −1.19 to −0.04, I2 = 67%). There were, however, no differences in the post‐operative INR (WMD −0.04, 95% CI −0.19 to 0.12, I2 = 96%) and ALT (WMD ‐94.94, 95% CI −228.46 to 40.38; I2 = 67%). More importantly, there were no statistically significant differences in length of stay, transfusion rates, and morbidity between the two groups.Conclusion: The administration of NAC in liver resection did not alter important biochemical parameters suggesting any real effectiveness in reducing hepatic dysfunction. There were no improvements in the clinical outcomes of length of stay, transfusion rates, and overall morbidity.
- 5 August 2024
- Published by Wiley in Anz Journal of Surgery
- Vol. 94 (10) , 1693-1701
Systematic review and meta‐analysis of the effect of N‐acetylcysteine on outcomes after liver resection
Background: N‐Acetylcysteine (NAC) is a recognized antioxidative agent that facilitates the conjugation of toxic metabolites. In recent years, NAC has been routinely used to limit ischaemia‐reperfusion injury in liver transplantation. There remains, however, contradictory evidence on its effectiveness in liver resection. This meta‐analysis examines the effectiveness of NAC in improving outcomes following hepatectomy.Methods: A comprehensive search of the MEDLINE, EMBASE, and Cochrane databases was performed to identify relevant randomized controlled trials (RCTs) published since database inception until November 2023. The outcomes of Day 1 biochemical markers (lactate, ALT, bilirubin, and INR), length of stay, transfusion rates, and morbidity were extracted. Quantitative pooling of data was based on a random‐effects model. The study protocol was registered on PROSPERO (Registration no: CRD42023442429).Results: Five RCTs reporting on 388 patients undergoing hepatectomy were included in the analysis. There were no significant differences in patient demographics between groups. Post‐operative lactate was lower in patients receiving NAC (WMD −0.61, 95% CI −1.19 to −0.04, I2 = 67%). There were, however, no differences in the post‐operative INR (WMD −0.04, 95% CI −0.19 to 0.12, I2 = 96%) and ALT (WMD ‐94.94, 95% CI −228.46 to 40.38; I2 = 67%). More importantly, there were no statistically significant differences in length of stay, transfusion rates, and morbidity between the two groups.Conclusion: The administration of NAC in liver resection did not alter important biochemical parameters suggesting any real effectiveness in reducing hepatic dysfunction. There were no improvements in the clinical outcomes of length of stay, transfusion rates, and overall morbidity.
- Open Access
- 27 May 2023
- Published by Elsevier in Clinical Nutrition
- Vol. 42 (7) , 1086-1094
Risk of osteopaenia, osteoporosis and osteoporotic fractures in patients with chronic pancreatitis: A systematic review and meta-analysis
- 27 May 2023
- Published by Elsevier in Clinical Nutrition
- Vol. 42 (7) , 1086-1094
Open AccessRisk of osteopaenia, osteoporosis and osteoporotic fractures in patients with chronic pancreatitis: A systematic review and meta-analysis
- Open Access
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Open AccessEffects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 11 November 2021
- Published by Wiley in World Journal of Surgery
- Vol. 46 (2) , 441-449
Safety and Efficacy of Tranexamic Acid to Minimise Perioperative Bleeding in Hepatic Surgery: A Systematic Review and Meta‐Analysis
Introduction: Perioperative bleeding poses a major risk during liver surgery, which can result in increased transfusion requirements, morbidity, and mortality. Tranexamic acid (TXA) effectively reduces perioperative bleeding and transfusion requirements in trauma patients. However, there remains a lack of evidence of its use in liver surgery. This meta‐analysis of randomised controlled trials evaluated the efficacy and safety of TXA in liver resection and transplantation.Method: A comprehensive search of Medline, Embase, CENTRAL and Clinicaltrials.gov databases was undertaken to identify studies from January 1947 to September 2021. The outcomes of the need for blood transfusion, thromboembolic events and mortality were extracted from the included studies. Quantitative pooling of data was based on the random effects model.Results: Six studies reporting on 429 patients were included. TXA reduced the need for perioperative blood transfusion in liver resection and transplantation (OR 0.09; 95% CI 0.01 to 0.72). More importantly, TXA did not increase the incidence of thromboembolic events (OR 2.22; 95% CI 0.47 to 10.43) and mortality (OR 0.60; 95% CI 0.13 to 2.76).Conclusion: TXA safely reduces the need for blood transfusion in patients undergoing liver resection and transplantation.
- 11 November 2021
- Published by Wiley in World Journal of Surgery
- Vol. 46 (2) , 441-449
Safety and Efficacy of Tranexamic Acid to Minimise Perioperative Bleeding in Hepatic Surgery: A Systematic Review and Meta‐Analysis
Introduction: Perioperative bleeding poses a major risk during liver surgery, which can result in increased transfusion requirements, morbidity, and mortality. Tranexamic acid (TXA) effectively reduces perioperative bleeding and transfusion requirements in trauma patients. However, there remains a lack of evidence of its use in liver surgery. This meta‐analysis of randomised controlled trials evaluated the efficacy and safety of TXA in liver resection and transplantation.Method: A comprehensive search of Medline, Embase, CENTRAL and Clinicaltrials.gov databases was undertaken to identify studies from January 1947 to September 2021. The outcomes of the need for blood transfusion, thromboembolic events and mortality were extracted from the included studies. Quantitative pooling of data was based on the random effects model.Results: Six studies reporting on 429 patients were included. TXA reduced the need for perioperative blood transfusion in liver resection and transplantation (OR 0.09; 95% CI 0.01 to 0.72). More importantly, TXA did not increase the incidence of thromboembolic events (OR 2.22; 95% CI 0.47 to 10.43) and mortality (OR 0.60; 95% CI 0.13 to 2.76).Conclusion: TXA safely reduces the need for blood transfusion in patients undergoing liver resection and transplantation.